Brief: Carl Zeiss Meditec 9M EBIT Margin Was 10.9%

Carl Zeiss Meditec AG

06/08/2024 06:05

Aug 6 (Reuters) - CARL ZEISS MEDITEC AG  AFXG.DE :
    * CLOSES FIRST NINE MONTHS OF 2023/24 WITH SLIGHT DECLINE IN
REVENUE
    * 9M EBIT MARGIN WAS 10.9%
    * ADJUSTED EBIT IS EXPECTED TO RANGE BETWEEN AROUND EUR 225M
TO
EUR 275M
    * FORECAST FOR FY AS A WHOLE PROJECTS REVENUE ON A
COMPARABLE
BASIS OF AROUND EUR 2,000M
    * IN MEDIUM TERM, EBIT MARGIN IS EXPECTED TO RECOVER AND
MOVE BACK
IN DIRECTION OF AROUND 20%
    * EXPECTS ALSO CONTRIBUTION TO FY REVENUE FROM ACQUISITION
OF DORC
OF AROUND EUR 100M

Source text for Eikon:  ID:nEQ1R4Jtna 
Further company coverage:  AFXG.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))